Mild depression affects HCV treatment success, study says

09/9/2011 | Medscape (free registration)

Mildly depressed patients with hepatitis C virus who begin interferon-based antiviral therapy could see their depression symptoms worsen, which may make it more likely they will discontinue treatment, researchers reported in the American Journal of Gastroenterology. The study team from the Veterans Affairs Palo Alto Health Care System and Stanford University also found that 53% of minimally depressed patients did not achieve a sustained virologic response to treatment, compared with those who were mildly or moderately depressed. Read the abstract.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY